Recombinant multi-species STK39 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK39 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a serine/threonine kinase that is thought to function in the cellular stress response pathway. The kinase is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. [provided by RefSeq, Jul 2008]
The Alternative Names of target: DCHT,Gm50618,PASK,RF005,Rnl5,SPAK,STE20/SPS1-related proline-alanine-rich protein kinase,STK39,Serine/threonine-protein kinase 39,Spak,Ste-20-related kinase,Stk39
Go
to STK39 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T67837-Ag-1/ GM-Tg-hg-T67837-Ag-2 | Human STK39 protein | Human |
| GM-Tg-rg-T67837-Ag-1/ GM-Tg-rg-T67837-Ag-2 | Rat STK39 protein | Rat |
| GM-Tg-mg-T67837-Ag-1/ GM-Tg-mg-T67837-Ag-2 | Mouse STK39 protein | Mouse |
| GM-Tg-cynog-T67837-Ag-1/ GM-Tg-cynog-T67837-Ag-2 | Cynomolgus/Rhesus macaque STK39 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T67837-Ag-1/ GM-Tg-felg-T67837-Ag-2 | Feline STK39 protein | Feline |
| GM-Tg-cang-T67837-Ag-1/ GM-Tg-cang-T67837-Ag-2 | Canine STK39 protein | Canine |
| GM-Tg-bovg-T67837-Ag-1/ GM-Tg-bovg-T67837-Ag-2 | Bovine STK39 protein | Bovine |
| GM-Tg-equg-T67837-Ag-1/ GM-Tg-equg-T67837-Ag-2 | Equine STK39 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T67837-Ag-1/ GM-Tg-hg-T67837-Ag-2;
GM-Tg-rg-T67837-Ag-1/ GM-Tg-rg-T67837-Ag-2;
GM-Tg-mg-T67837-Ag-1/ GM-Tg-mg-T67837-Ag-2; GM-Tg-cynog-T67837-Ag-1/ GM-Tg-cynog-T67837-Ag-2; GM-Tg-felg-T67837-Ag-1/ GM-Tg-felg-T67837-Ag-2; GM-Tg-cang-T67837-Ag-1/ GM-Tg-cang-T67837-Ag-2; GM-Tg-bovg-T67837-Ag-1/ GM-Tg-bovg-T67837-Ag-2; GM-Tg-equg-T67837-Ag-1/ GM-Tg-equg-T67837-Ag-2 |
| Products Name | STK39 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | STK39 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK39 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.